Alanine-Glyoxylate Aminotransferase 2-Like 2 (AGXT2L2) (Middle Region) Peptide
Quick Overview for Alanine-Glyoxylate Aminotransferase 2-Like 2 (AGXT2L2) (Middle Region) Peptide (ABIN5512122)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- WVHVAPLPDT YRGPYREDHP NPAMAYANEV KRVVSSAQEK GRKIAAFFAE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- AGXT2L2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AGXT2L2 (Alanine-Glyoxylate Aminotransferase 2-Like 2 (AGXT2L2))
-
Background
-
This is a nuclear gene encoding a mitochondrial enzyme that catalyzes the conversion of 5-phosphonooxy-L-lysine to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. Mutations in this gene may cause phosphohydroxylysinuria. Alternative splicing results in multiple transcript variants.
Alias Symbols: PHLU, AGXT2L2
Protein Size: 450 -
Gene ID
- 85007
-
NCBI Accession
- NM_001278346, NP_001265275
-
UniProt
- Q8IUZ5
Target
-